SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
A controlled, randomized, open-label, multicenter study evaluating if early initiation of
everolimus and early elimination of cyclosporine in de novo heart transplant recipients can
improve long-term renal function and slow down the progression of chronic allograft
vasculopathy